Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 12 records per page: next > | last >>
pages: 1 2 3 4 5 ... 9 10 11 12 presentations: 1 to 25 of 300
Designing Biomarker Studies to Achieve Desired Clinical Applications
Intended clinical application drives your study design: Principles and operational considerations
Ziding Feng
Fred Hutchinson Cancer Research Ctr., Seattle, WA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Designing Biomarker Studies to Achieve Desired Clinical Applications
Evaluating biomarkers for prognostic enrichment of clinical trials
Kathleen Kerr
University of Washington, Seattle, WA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Designing Biomarker Studies to Achieve Desired Clinical Applications
Deriving early detection biomarker performance goals by setting a minimum benefit-to-harm ratio
Steven J Skates
Massachusetts General Hospital, Boston, MA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Integrating Tumor Immunology and Molecular Epidemiology
Introduction
Melissa L Bondy
Baylor College of Medicine, Dan L. Duncan Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Integrating Tumor Immunology and Molecular Epidemiology
Integration of immunology (+ microbiology and genomics) into epidemiology 101
Shuji Ogino
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Integrating Tumor Immunology and Molecular Epidemiology
Immune analysis of ovarian cancer: Multiple datasets, multiple datatypes
Ellen L Goode
Mayo Clinic, Rochester, MN, United States
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Integrating Tumor Immunology and Molecular Epidemiology
Computational modeling of tumor immunology from bulk RNA-seq data
X. Shirley Liu
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Obesity: The Effects of Local and Systemic Inflammation on Cancer
Introduction: A brief overview of adipose tissue metabolism
Ernst R Lengyel
Univ. of Chicago, Chicago, IL, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
Obesity: The Effects of Local and Systemic Inflammation on Cancer
Paracrine role of mammary adipocytes in breast cancer progression and drug resistance
Catherine Muller
Institut de Pharmacologie et de Biologie Structurale, Toulouse, France
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
Obesity: The Effects of Local and Systemic Inflammation on Cancer
The contribution of adipose fatty acid binding protein in cancer progression
Bing Li
Univ. of Louisville School of Medicine, Louisville, KY, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
Obesity: The Effects of Local and Systemic Inflammation on Cancer
  •  
  • Free
  • Coming soon
  • Some slides withheld
  •  
  •  
Adipose stromal cell role in EMT and chemoresistance
Mikhail Kolonin
The University of Texas Health Science Center at Houston, Houston, TX, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
Obesity: The Effects of Local and Systemic Inflammation on Cancer
Cancer and obesity: Stromal contributions of adipocytes to cancer progression
Philipp E. Scherer
UT Southwestern Medical Ctr., Dallas, TX, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
BRCA1 Variants of Unknown Significance (VUS): New Vistas in the Assessment of Cancer Risk
BRCA1: We have come a long way, baby!
Roy A Jensen
Univ. of Kansas Cancer Ctr., Kansas City, KS, United States
from AACR Annual Meeting 2019 on March 30, 2019 3:15 PM-5:15 PM
BRCA1 Variants of Unknown Significance (VUS): New Vistas in the Assessment of Cancer Risk
Risk assessment for carriers of BRCA variants of uncertain significance (VUS)
Fergus J Couch
Mayo Clinic, Rochester, MN, United States
from AACR Annual Meeting 2019 on March 30, 2019 3:15 PM-5:15 PM
BRCA1 Variants of Unknown Significance (VUS): New Vistas in the Assessment of Cancer Risk
High throughput analysis of BRCA1 variants for function in DNA repair
Jeffrey D. Parvin
Ohio State University Medical Center, Columbus, OH, United States
from AACR Annual Meeting 2019 on March 30, 2019 3:15 PM-5:15 PM
BRCA1 Variants of Unknown Significance (VUS): New Vistas in the Assessment of Cancer Risk
VUS: why they matter
Susan M. Domchek
Abramson Cancer Center of University of Pennsylvania, Philadelphia, PA, United States
from AACR Annual Meeting 2019 on March 30, 2019 3:15 PM-5:15 PM
The Changing Face of Ovarian Cancer
The journey of PARP inhibitors to the front line of ovarian cancer
Shannon N Westin
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2019 on March 31, 2019 1:00 PM-2:45 PM
The Changing Face of Ovarian Cancer
From pathogenesis to targets in ovarian cancer
Ronny I Drapkin
University of Pennsylvania, Philadelphia, PA, United States
from AACR Annual Meeting 2019 on March 31, 2019 1:00 PM-2:45 PM
The Changing Face of Ovarian Cancer
Invited Speaker
Gordon B Mills
OHSU Knight Cancer Inst., Portland, OR, United States
from AACR Annual Meeting 2019 on March 31, 2019 1:00 PM-2:45 PM
Cancer Detection with Proximate Biologic Specimens
Detection of endometrial cancer in lower genital tract specimens
Mark E Sherman
Mayo Clinic Cancer Ctr. Jacksonville, Jacksonville, FL, United States
from AACR Annual Meeting 2019 on April 1, 2019 10:30 AM-12:15 PM
Cancer Detection with Proximate Biologic Specimens
  •  
  • Free
  • Unknown permission
    for presentation
  •  
  •  
Intercepting lung cancer via the airway field of injury
Avrum E Spira
Boston Univ. School of Medicine, Boston, MA, United States
from AACR Annual Meeting 2019 on April 1, 2019 10:30 AM-12:15 PM
Cancer Detection with Proximate Biologic Specimens
Lessons from studying molecular markers in stool for CRC screening
David F Ransohoff
Univ. of North Carolina at Chapel Hill, Chapel Hill, NC, United States
from AACR Annual Meeting 2019 on April 1, 2019 10:30 AM-12:15 PM
Multilevel Consideration of Cancer Health Disparities: Contextual Factors to Molecular Features
Chairperson
Jennifer A Doherty
Huntsman Cancer Institute, Salt Lake City, UT, United States
from AACR Annual Meeting 2019 on April 1, 2019 10:30 AM-12:15 PM
Multilevel Consideration of Cancer Health Disparities: Contextual Factors to Molecular Features
Building infrastructures to address multilevel determinants of cancer health disparities
Scarlett L Gomez
UCSF, San Francisco, CA, United States
from AACR Annual Meeting 2019 on April 1, 2019 10:30 AM-12:15 PM
Multilevel Consideration of Cancer Health Disparities: Contextual Factors to Molecular Features
Environmental, behavioral, social, and genomic factors underlying cancer health disparities in Hispanic and American Indian populations of the American southwest
Cheryl L Willman
Univ. of New Mexico Comprehensive Cancer Ctr., Albuquerque, NM, United States
from AACR Annual Meeting 2019 on April 1, 2019 10:30 AM-12:15 PM
<< first | < prev page: of 12 records per page: next > | last >>
pages: 1 2 3 4 5 ... 9 10 11 12 presentations: 1 to 25 of 300